CPH — Cipher Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- CA$339.41m
- CA$327.17m
- $50.45m
Brief: Cipher Pharmaceuticals Reports Qtrly Total Net Revenue Increased By 90% To $12.2 Million
Brief: Cipher Pharmaceuticals Acquires Exclusive Canadian Rights To FDA-Approved Trulance From Synergy Pharma
Brief: Cipher Pharma And Italmex Pharma Announce Exclusive Distribution Agreement For Isotretinoin Product In Mexico
Brief: Cipher Pharma Announces Canadian Launch of OZANEX
Brief: Cipher Pharmaceuticals announces new credit facility
Brief: Cipher Pharmaceuticals Q3 earnings per basic share from continuing operations $0.15
Brief: Cipher Pharmaceuticals comments on supply chain impact from Hurricane Maria
Brief: Cipher Pharma comments on FDA warning letter for ConZip(Tramadol)
Brief: Cipher Pharmaceuticals reports Q2 revenue of $9.9 million
Brief: Cipher Pharmaceuticals Q1 loss per share $0.06 from continuing operations
Brief: Cipher Pharmaceuticals receives Health Canada approval of Ozanex
Brief: Cipher Pharmaceuticals announces sale of U.S. Commercial assets to EPI Group
Brief: Cipher Pharmaceuticals says Robert Tessarolo and Arthur Deboeck proposed for election to co's board
Brief: Cipher Pharmaceuticals announces amendment to debt agreement and partial prepayment
Brief: Cipher Pharmaceuticals appoints Robert Tessarolo as CEO
Brief: Cipher Pharmaceuticals Q4 net loss $11.3 million
Brief: Cipher Pharmaceuticals announces plans to voluntarily delist from NASDAQ
Brief: Cipher Pharmaceuticals reports Q3 2016 financial results
Brief: Cipher Pharmaceuticals reports Q3 2016 financial results